|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cryptocurrency News Articles
These 2 Catalysts Might End the Consolidation of Ripple (XRP)
Mar 20, 2025 at 01:58 pm
At a time when the crypto market is exhibiting volatile dynamics, two catalysts might end the consolidation of Ripple (XRP)

At a time when the crypto market is exhibiting volatile dynamics, two catalysts might end the consolidation of Ripple (XRP) price.
The significant rise in the number of active addresses and the upcoming DC Blockchain Summit on March 26, 2025 were the main highlights.
This article will dig into the possibility of Ripple (XRP) breaking the current price stagnation ahead of the key event.
Ripple (XRP) Price Increase Potential
From a technical perspective, the current (3/19) price of Ripple (XRP) is within the range of $2.057 to $2.724. After deviating from the lower boundary of the range on March 11, the token has surged 30% to reach a local peak of $2.47.
For the trend to remain bullish, Ripple (XRP) needs to register a higher low above $2,057. This will push the price to revisit the upper limit of the range at $2,724.
In a very bullish scenario, if Bitcoin (BTC) price surges further to $80,000 or higher, then there is a chance for Ripple (XRP) to rally to $3 or higher.
This move would equal a gain of almost 40%, assuming the Ripple (XRP) price records a higher low of $2.1571.
Triple Increase in Ripple (XRP) Active Addresses
On December 2, 2024, the price of Ripple (XRP) touched $2.69 for the first time in over five years. This level recorded a peak Daily Active Address (DAA) of 165,000.
Since then, this on-chain metric has shown a decline, indicating reduced investor interest. However, DAA more than tripled to 530,000 on March 2. This sudden spike suggests that investors are interested in the current price level.
As the DAA surge has persisted over the past two weeks, this suggests that Ripple (XRP) holders are anticipating something big in the coming days.
The DC Blockchain Summit, where many well-known crypto figures and US government officials gathered to discuss cryptocurrencies, became a pivotal point. Given that Ripple is a US-based company, this Summit could reveal the role of Ripple and other key cryptocurrencies in advancing America as a crypto capital.
Possible Ripple (XRP) Price Increase to $3
Given the significant increase in DAA and the upcoming DC Blockchain Summit, the chances of Ripple (Xരു
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
-
- Datavecta Forges Global Community Ecosystem to Power International Growth Through Advanced SEO Strategy
- Sep 30, 2026 at 07:55 pm
- Datavecta is building a global community ecosystem to enhance international growth, leveraging advanced SEO strategies and technology-driven services for a connected intelligent trading future.
-
- Illinois Rolls Out Draft Rules for 0.2% Crypto Transaction Tax, Set for 2027
- Sep 30, 2026 at 12:05 pm
- Illinois unveils draft regulations for its upcoming 0.2% digital asset transaction tax, impacting exchanges, transfers, and custody services starting January 1, 2027. The tax applies to the gross value of transactions, not investment gains.
-
-
- Apeing Leads the Charge: Unveiling the Next 100x Crypto Watchlist and 6 Coins to Eye
- Sep 30, 2026 at 12:03 pm
- Amidst a dynamic crypto market, Apeing's presale momentum, coupled with established players like Solana and TRON, is redefining the 100x crypto narrative, offering both early-stage opportunities and proven network strength.
-
-
- OpenAI Unveils GPT-6.1 Sol and Ultrafast Tier, While AstraZeneca Invests Big in Summit Therapeutics
- Sep 30, 2026 at 08:05 am
- OpenAI rolls out GPT-6.1 Sol, offering near-Astra performance at a fraction of the cost, alongside a new 'Ultrafast' speed tier. Meanwhile, AstraZeneca makes a significant $2 billion investment in oncology firm Summit Therapeutics.
-
-
































